Impairment of baroreflex control of heart rate in conscious transgenic mice of type 1 diabetes (OVE26)

Autonomic Neuroscience: Basic and Clinical

Volumn 152, Issue 1-2, 2010, Pages 67-74

  Lin, Min ^a   Harden, Scott W ^a   Li, Lihua ^a   Wurster, Robert D ^b  

^a Jack)   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Baroreflex; Cardiac ganglia; Heart; Nucleus ambiguus; OVE26 diabetic mice

Indexed keywords

NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; ATTENUATION; BIRTH; BRADYCARDIA; CATHETERIZATION; COMPARATIVE STUDY; CONSCIOUSNESS; CONTROL GROUP; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMORAL ARTERY; FEMORAL VEIN; HEART RATE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; BRADYCARDIA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HEART RATE; MALE; MICE; MICE, TRANSGENIC; NITROPRUSSIDE; PHENYLEPHRINE; TACHYCARDIA; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; WAKEFULNESS;

EID: 72049129403     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2009.09.020     Document Type: Article

References (40)

1. Ahlgren A.R., Astrand H., Sundkvist G., and Länne T. Increased aortic stiffness is persistent in type 1 diabetic women: a follow-up study. Diabetologia 48 (2005) 780-783
2. Ai J., Liu B., Gozal D., Epstein P., and Cheng Z.J.*. Cardiac neuropathy in type I diabetic mice (OVE26). Annual Conference for Experimental Biology, The Moscone Convention Center, San Francisco, CA. April 1-5, 2006 (2006) 73
3. Dalla Pozza R., Bechtold S., Bonfig W., Putzker S., Kozlik-Feldmann R., Schwarz H.P., and Netz H. Impaired short-term blood pressure regulation and autonomic dysbalance in children with type 1 diabetes mellitus. Diabetologia 50 (2007) 2417-2423
4. Dall'ago P., D'Agord Schaan B., da Silva V.O., Werner J., da Silva Soares P.P., De Angelis K., and Irigoyen M.C. Parasympathetic dysfunction is associated with baroreflex and chemoreflex impairment in streptozotocin-induced diabetes in rats. Auton. Neurosci. 131 (2007) 28-35
5. De Angelis K., Schaan B.D., Maeda C.Y., Dall'Ago P., Wichi R.B., and Irigoyen M.C. Cardiovascular control in experimental diabetes. Braz. J. Med. Biol. Res. 35 (2002) 1091-1100
6. El-Menyar A.A. Dysrhythmia and electrocardiographic changes in diabetes mellitus: pathophysiology and impact on the incidence of sudden cardiac death. J. Cardiovasc. Med. (Hagerstown) 7 (2006) 580-855
7. Epstein P.N., Overbeek P.A., and Means A.R. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58 (1989) 1067-1073
8. Frattola A., Parati G., Gamba P., et al. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 40 (1997) 1470-1475
9. Greene D.A., De Jesus Jr. P.V., and Winegrad A.I. Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. J. Clin. Invest. 55 (1975) 1326-1336
10. Greene D.A., and Lattimer S.A. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J. Clin. Invest. 72 (1983) 1058-1063
11. Gross V., Tank J., Partke H.J., Plehm R., Diedrich A., da Costa Goncalves A.C., Luft F.C., and Jordan J. Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice. Auton. Neurosci. 138 (2008) 108-113
12. Gu H., Epstein P.N., Wurster R.D., and Cheng Z.J. Functional changes in baroreceptor afferent, central and efferent components of the baroreflex circuitry in type 1 diabetic mice (OVE26). Neuroscience 152 (2008) 741-752
13. Gu H., Zhang Z.-H., Epstein P.N., Li L., Harden S.W., Wurster R.D., Cheng Z.J., 2009. Impaired baroreflex control of renal sympathetic nerve activity (RSNA) in Type 1 diabetic mice (OVE26). Neuroscience 161, 78-85.
14. Huang W.C., Fang T.C., and Cheng J.T. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension 32 (1998) 249-254
15. Huang C., Li L., Shang X., Epstein P.N., and Cheng Z. Structural remodeling of nucleus ambiguus (NA) projections to cardiac ganglia in transgenic type 1 diabetic mice (OVE26). FASEB J. 22 (2008) 950.2-
16. Huang C., Li L., Yan B., Epstein P.N., and Cheng Z. Structural remodeling of baroreceptor afferent innervation of aortic arch in transgenic type 1 diabetic mice (OVE 26). FASEB J. 22 (2008) 950.3-
17. Inada A., Kanamori H., Arai H., Akashi T., Araki M., Weir G.C., and Fukatsu A. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. J. Cell Physiol. 215 (2008) 383-391
18. Krause M., Rüdiger H., Bald M., Näke A., and Paditz E. Autonomic blood pressure control in children and adolescents with type 1 diabetes mellitus. Pediatr. Diabetes 10 (2009) 255-263
19. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., and Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51 (2002) 174-181
20. + Channels Cardiac Motoneurons in the Nucleus Ambiguus (NA) of Neonatal Mice. Annual Conference for Experimental Biology, San Diego, CA. April 5-9 (2008)
21. + (BK) Current of Cardiac Motoneurons in the Nucleus Ambiguus (NA) of Neonatal Mice. Annual Conference for Experimental Biology, San Diego, CA. April 5-9 (2008)
22. Liu I.M., Chang C.K., Juang S.W., Kou D.H., Tong Y.C., Cheng K.C., and Cheng J.T. Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats. Int. J. Exp. Pathol. 89 (2008) 292-300
23. Lucini D., Mela G.S., Malliani A., and Pagani M. Impairment in cardiac autonomic regulation preceding arterial hypertension in humans. Circulation 106 (2002) 2673-2679
24. McDowell T.S., Chapleau M.W., Hajduczok G., and Abboud F.M. Baroreflex dysfunction in diabetes mellitus. I. Selective impairment of parasympathetic control of heart rate. Am. J. Physiol. 266 1 Pt 2 (1994) H235-H243
25. McDowell T.S., Hajduczok G., Abboud F.M., and Chapleau M.W. Baroreflex dysfunction in diabetes mellitus. II. Site of baroreflex impairment in diabetic rabbits. Am. J. Physiol. 1 Pt 2 (1994) H244-H249
26. Perin P.C., Maule S., and Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin. Exp. Hypertens. 23 (2001) 45-55
27. Ruiz J., Monbaron D., Parati G., Perret S., Haesler E., Danzeisen C., and Hayoz D. Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes. Hypertension 46 (2005) 162-167
28. Schmidt R.E., Dorsey D.A., Beaudet L.N., Frederick K.E., Parvin C.A., Plurad S.B., and Levisetti M.G. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. Am. J. Pathol. 163 (2003) 2077-2091
29. Shen X., Ye G., Metreveli N.S., and Epstein P.N. Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Methods Mol. Med. 112 (2005) 379-388
30. Shoham S., Bejar C., Kovalev E., and Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp. Neurol. 184 (2003) 1043-1052
31. van Ittersum F.J., Schram M.T., van der Heijden-Spek J.J., Van Bortel L.M., Elte J.W., Biemond P., Staessen J.A., Donker A.J., and Stehouwer C.D. Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J. Hum. Hypertens. 18 (2004) 761-768
32. Vinik A.I., and Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 115 (2007) 387-397
33. Weston P.J., Panerai R.B., McCullough A., McNally P.G., James M.A., Potter J.F., Thurston H., and Swales J.D. Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index. Diabetologia 39 (1996) 1385-1391
34. Weston P.J., James M.A., Panerai R., McNally P.G., Potter J.F., Thurston H., and Swales J.D. Abnormal baroreceptor-cardiac reflex sensitivity is not detected by conventional tests of autonomic function in patients with insulin-dependent diabetes mellitus. Clin. Sci. (Lond.) 91 (1996) 59-64
35. Xue B., Pamidimukkala J., and Hay M. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am. J. Physiol. Heart Circ. Physiol. 288 5 (2005) H2177-H2184
36. Yan B., Li L., Harden S.W., Wurster R.D., and Cheng Z.J. Diabetes induces neural degeneration in nucleus ambiguus (NA) and attenuates heart rate control in OVE26 mice. Exp. Neurol. 220 (2009) 34-43
37. Ye G., Metreveli N.S., Ren J., and Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52 (2003) 777-783
38. Ye G., Metreveli N.S., Donthi R.V., Xia S., Xu M., Carlson E.C., and Epstein P.N. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53 (2004) 1336-1343
39. Zheng S., Noonan W.T., Metreveli N.S., Coventry S., Kralik P.M., Carlson E.C., and Epstein P.N. Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 53 (2004) 3248-3257
40. Zheng S., Carlson E.C., Yang L., Kralik P.M., Huang Y., and Epstein P.N. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. J. Am. Soc. Nephrol. 19 (2008) 2077-2085